These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20205282)

  • 1. Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.
    Kuriyama M; Kato J; Takemoto K; Hiraoka S; Okada H; Yamamoto K
    World J Gastroenterol; 2010 Mar; 16(9):1110-4. PubMed ID: 20205282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consecutive Measurements by Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Detect Clinical Relapse.
    Hiraoka S; Kato J; Nakarai A; Takashima S; Inokuchi T; Takei D; Sugihara Y; Takahara M; Harada K; Okada H
    J Crohns Colitis; 2016 Jun; 10(6):687-94. PubMed ID: 26802083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of disease activity by fecal immunochemical test in ulcerative colitis.
    Ryu DG; Kim HW; Park SB; Kang DH; Choi CW; Kim SJ; Nam HS
    World J Gastroenterol; 2016 Dec; 22(48):10617-10624. PubMed ID: 28082814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
    Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
    Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
    Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
    World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
    Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
    Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
    Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
    J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta-analysis.
    Dai C; Jiang M; Sun MJ; Cao Q
    J Gastroenterol Hepatol; 2018 May; 33(5):990-997. PubMed ID: 29427297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of fecal occult blood on obscure gastrointestinal bleeding: observational study.
    Kobayashi Y; Watabe H; Yamada A; Suzuki H; Hirata Y; Yamaji Y; Yoshida H; Koike K
    World J Gastroenterol; 2015 Jan; 21(1):326-32. PubMed ID: 25574108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and prediction of corticosteroid therapy after successive courses of ulcerative colitis treatments.
    Barreiro-Alonso E; Saro-Gismera C; Sánchez M
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):733-741. PubMed ID: 29911903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
    Schoepfer AM; Beglinger C; Straumann A; Safroneeva E; Romero Y; Armstrong D; Schmidt C; Trummler M; Pittet V; Vavricka SR
    Inflamm Bowel Dis; 2013 Feb; 19(2):332-41. PubMed ID: 23328771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.
    De Vos M; Louis EJ; Jahnsen J; Vandervoort JG; Noman M; Dewit O; Dʼhaens GR; Franchimont D; Baert FJ; Torp RA; Henriksen M; Potvin PM; Van Hootegem PP; Hindryckx PM; Moreels TG; Collard A; Karlsen LN; Kittang E; Lambrecht G; Grimstad T; Koch J; Lygren I; Coche JC; Mana F; Van Gossum A; Belaiche J; Cool MR; Fontaine F; Maisin JM; Muls V; Neuville B; Staessen DA; Van Assche GA; de Lange T; Solberg IC; Vander Cruyssen BJ; Vermeire SA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2111-7. PubMed ID: 23883959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
    Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
    Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.